220 related articles for article (PubMed ID: 22957815)
1. The role of clofarabine in acute myeloid leukemia.
Ghanem H; Kantarjian H; Ohanian M; Jabbour E
Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
[TBL] [Abstract][Full Text] [Related]
2. Clofarabine in leukemia.
Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
[TBL] [Abstract][Full Text] [Related]
3. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Kline JP; Larson RA
Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
[TBL] [Abstract][Full Text] [Related]
6. Clofarabine: emerging role in leukemias.
Sampat K; Kantarjian H; Borthakur G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
8. Clofarabine in the treatment of myelodysplastic syndromes.
Bryan J; Kantarjian H; Prescott H; Jabbour E
Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
[TBL] [Abstract][Full Text] [Related]
9. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
Tran H; Yang D
Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of anti-cancer action and pharmacology of clofarabine.
Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
[TBL] [Abstract][Full Text] [Related]
11. Clofarabine: past, present, and future.
Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
[TBL] [Abstract][Full Text] [Related]
12. The role of Clofarabine in the treatment of adults with acute myeloid leukemia.
Fozza C
Crit Rev Oncol Hematol; 2015 Mar; 93(3):237-45. PubMed ID: 25457773
[TBL] [Abstract][Full Text] [Related]
13. Clofarabine.
Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
[TBL] [Abstract][Full Text] [Related]
14. Clofarabine for the treatment of adult acute myeloid leukemia.
Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H
Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733
[TBL] [Abstract][Full Text] [Related]
15. Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Mathisen MS; Kantarjian H; Jabbour E; Garcia-Manero G; Ravandi F; Faderl S; Borthakur G; Cortes JE; Quintás-Cardama A
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):139-43. PubMed ID: 23276886
[TBL] [Abstract][Full Text] [Related]
16. Clofarabine in pediatric acute leukemia: current findings and issues.
Hijiya N; Barry E; Arceci RJ
Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
Jabbour E; Short NJ; Ravandi F; Huang X; Xiao L; Garcia-Manero G; Plunkett W; Gandhi V; Sasaki K; Pemmaraju N; Daver NG; Borthakur G; Jain N; Konopleva M; Estrov Z; Kadia TM; Wierda WG; DiNardo CD; Brandt M; O'Brien SM; Cortes JE; Kantarjian H
Cancer; 2017 Nov; 123(22):4430-4439. PubMed ID: 28708931
[TBL] [Abstract][Full Text] [Related]
18. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
Racil Z; Toskova M; Dvorakova D; Jeziskova I; Razga F; Buresova L; Timilsina S; Mayer J
Am J Hematol; 2012 Feb; 87(2):211-3. PubMed ID: 22052688
[TBL] [Abstract][Full Text] [Related]
19. Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
Faderl S; Ravandi F; Huang X; Wang X; Jabbour E; Garcia-Manero G; Kadia T; Ferrajoli A; Konopleva M; Borthakur G; Burger J; Feliu J; Kantarjian HM
Cancer; 2012 Sep; 118(18):4471-7. PubMed ID: 22282348
[TBL] [Abstract][Full Text] [Related]
20. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
Burnett AK; Russell NH; Kell J; Dennis M; Milligan D; Paolini S; Yin J; Culligan D; Johnston P; Murphy J; McMullin MF; Hunter A; Das-Gupta E; Clark R; Carr R; Hills RK
J Clin Oncol; 2010 May; 28(14):2389-95. PubMed ID: 20385984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]